Skip to main content

Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets Proceedings of a Symposium (2018) / Chapter Skim
Currently Skimming:

2 Molybdenum-99/Technetium-99m in Nuclear Medicine
Pages 9-12

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 9...
... According to the 2016 National Academies report, these factors are likely to continue to operate and result in further decline of Mo-99 demand. Indeed, articles have been published since the release of the 2016 NASEM report, indicating additional changes in medical insurance reimbursement policies related to medical imaging aiming to reduce medical costs.2 The 2016 National Academies report also noted a 25 percent decline 1  Medicare is the federal health insurance program in the United States for people 65 years of age and older and for those with permanent disabilities.
Read the entire page →
From page 10...
... confirmed that in China, Mo-99/Tc-99m utilization has increased by 5 percent during the past 5 years. He noted that the Chinese Society of Nuclear Medicine is focusing on efforts to develop nuclear medicine programs in the country and on training nuclear medicine physicians.
Read the entire page →
From page 11...
... The other ventilation agent in wide use in the United States is Tc-99m pentatate (DTPA) aerosol (an off-label use of an FDA-approved agent for renal and brain imaging)
Read the entire page →
From page 12...
... It has focused on providing assistance for developing nuclear medicine programs in low- and medium-income countries to help overcome several challenges these countries face related to • Training a multidisciplinary team of professionals, including physicians, medical physicists, radiographers, and radiochemists; • Assessing the impact of introducing novel high-cost health technologies and their sustainability; • Purchasing and utilizing high-cost equipment for nuclear medicine imaging and laboratory equipment for the nuclear pharmacy and providing for quality control; • Managing potential increases in healthcare costs; and • Complying with international standards where there is a lack of adequate infrastructure, quality assurance culture, and qualified human resources to do so. The IAEA's support for nuclear medicine programs is provided through technical cooperation projects.
Read the entire page →

Key Terms

  • medicine programs
  • medical insurance
  • artery disease
  • insurance reimbursement
  • reimbursement policies

  • coronary artery
  • academies report
  • percent decline
  • offering nuclear
  • ing nuclear

  • medicine program
  • medicine physicians
  • medicine imaging
  • medicine facilities
  • operate nuclear

  • designing nuclear
  • develop nuclear
  • medicine procedures
  • training nuclear
  • medicine expansion

  • medicine tests
  • developing nuclear
  • factors contributed
  • indicating additional
  • agents owing

  • auditing quality
  • lag time
  • ventilation agent
  • nasem report
  • easier quantification


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.